£79.99
Pack Size: 100-Tablet Pack
Artvigil 250mg Tablets contain 250mg of armodafinil as the active ingredient. Armodafinil is a wakefulness-promoting agent related to modafinil and is the R-enantiomer of modafinil. Artvigil is not a UK-licensed medicine, so it should not be presented as having a UK marketing authorisation or as a standard UK prescription product. The MHRA has identified armodafinil among unlicensed medicines used in the treatment of narcolepsy.
Armodafinil is used in some countries to improve wakefulness in adults with excessive daytime sleepiness associated with conditions including narcolepsy, obstructive sleep apnoea and shift work sleep disorder. However, these are not UK-authorised indications for Artvigil. In the UK, unlicensed medicines may only be supplied in appropriate circumstances under the relevant prescribing and importing arrangements, and unlicensed medicines have not been assessed by the MHRA in the same way as licensed medicines.
Armodafinil is the R-enantiomer of modafinil and acts on the central nervous system to promote wakefulness. Its precise mechanism is not completely understood, but its effects involve pathways associated with dopamine and the regulation of wakefulness. By promoting wakefulness, armodafinil can help reduce excessive daytime sleepiness in people with appropriately diagnosed sleep disorders. It does not cure an underlying sleep disorder and should not be used as a substitute for sufficient sleep.
Follow Medical Advice: Because Artvigil is an unlicensed armodafinil product in the UK, it should only be used when prescribed or supplied under appropriate medical supervision and according to the instructions provided by the responsible healthcare professional. Usual International Dosing: In countries where armodafinil is licensed, 250mg once daily is a commonly used dose for adults with narcolepsy or obstructive sleep apnoea, while 250mg taken approximately one hour before a work shift is used for shift work sleep disorder. These dosing recommendations should not be interpreted as UK-authorised dosing for Artvigil.
Like other wakefulness-promoting medication, armodafinil can cause side effects. Report persistent or troublesome symptoms to a healthcare professional, particularly if they affect sleep, mood, blood pressure or heart function.
Serious reactions can occur with armodafinil, including severe skin reactions and psychiatric symptoms. Seek urgent medical attention if a serious rash, blistering, swelling, difficulty breathing, hallucinations, severe agitation or significant changes in mood or behaviour develop.
Do not change or stop armodafinil treatment without discussing it with the healthcare professional responsible for your care. The need for continued wakefulness-promoting treatment should be reviewed regularly, particularly when treating a long-term sleep disorder.
Artvigil contains armodafinil, a wakefulness-promoting agent used in some countries for excessive daytime sleepiness associated with conditions such as narcolepsy, obstructive sleep apnoea and shift work sleep disorder. Artvigil itself is not a UK-licensed medicine, so these should not be described as UK-authorised indications.
No. Artvigil is not a UK-licensed medicine. The MHRA identifies armodafinil among unlicensed medicines, and UK rules allow certain unlicensed medicines to be supplied only in appropriate clinical circumstances.
In countries where armodafinil is licensed, 250mg once daily is a commonly used dose for certain approved sleep-related conditions. However, this does not make 250mg a UK-authorised Artvigil dose, and treatment should only follow the instructions of the responsible healthcare professional.
No. Where armodafinil is used internationally for residual sleepiness associated with obstructive sleep apnoea, it is used alongside appropriate treatment of the underlying condition rather than replacing it. Treatment of the underlying sleep disorder remains important.
Yes. Armodafinil may reduce the effectiveness of hormonal contraception. Anyone taking hormonal contraceptives should discuss alternative or additional contraception with a healthcare professional before using armodafinil.
No. Armodafinil is the R-enantiomer of modafinil, so the substances are closely related but are not identical. UK licensed modafinil products are available in 100mg and 200mg strengths, whereas Artvigil is an armodafinil product and is not UK licensed.
This content is provided for informational purposes only and does not constitute medical advice. These medications are prescription-only medicines (POM) in the UK and should only be used under the guidance and supervision of a qualified healthcare professional.